YASMIN 28 TABLET

Country: Kanada

Bahasa: Inggeris

Sumber: Health Canada

Bahan aktif:

DROSPIRENONE; ETHINYL ESTRADIOL

Boleh didapati daripada:

BAYER INC

Kod ATC:

G03AA12

INN (Nama Antarabangsa):

DROSPIRENONE AND ESTROGEN

Dos:

3MG; 0.03MG

Borang farmaseutikal:

TABLET

Komposisi:

DROSPIRENONE 3MG; ETHINYL ESTRADIOL 0.03MG

Laluan pentadbiran:

ORAL

Unit dalam pakej:

28

Jenis preskripsi:

Prescription

Kawasan terapeutik:

CONTRACEPTIVES

Ringkasan produk:

Active ingredient group (AIG) number: 0250430001; AHFS:

Status kebenaran:

APPROVED

Tarikh kebenaran:

2004-12-10

Ciri produk

_ _
_YASMIN Product Monograph _
_ _
_Page 1 of 58 _
_ _
PRODUCT MONOGRAPH
PR
YASMIN
® 21
PR
YASMIN
® 28
Drospirenone and Ethinyl Estradiol Tablets, Bayer Standard
3.0 mg drospirenone and 0.030 mg ethinyl estradiol
Oral Contraceptive
Acne Therapy
Bayer Inc.
2920 Matheson Boulevard East
Mississauga, Ontario
L4W 5R6
Canada
http://www.bayer.ca
Date of Revision:
April 8, 2021
Submission Control No: 196901
©2017, Bayer Inc.
® TM see www.bayer.ca/tm-mc
_ _
_YASMIN Product Monograph _
_ _
_Page 2 of 58 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
..................................................................................................14
DRUG INTERACTIONS
..................................................................................................18
DOSAGE AND ADMINISTRATION
..............................................................................25
OVERDOSAGE
................................................................................................................27
ACTION AND CLINICAL PHARMACOLOGY
............................................................28
STORAGE AND STABILITY
..........................................................................................32
SPECIAL HANDLING INSTRUCTIONS
.......................................................................32
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................32
PART II: SCIENTIFIC INFORMATION
...........................................................................